首页> 外文期刊>The journal of clinical psychiatry >Prevalence and Predictors of Benzodiazepine Monotherapy in Patients With Depression: A National Cross-Sectional Study
【24h】

Prevalence and Predictors of Benzodiazepine Monotherapy in Patients With Depression: A National Cross-Sectional Study

机译:抑郁症患者苯并二氮杂卓的患病率和预测因子:全国横断面研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Depression guidelines discourage benzodiazepine monotherapy and limit use to short-term adjunctive therapy with antidepressants; however, patients with depression continue to receive benzodiazepine monotherapy.The prevalence and predictors of this prescribing pattern have not been described previously and are warranted to assist clinicians in identifying patients at highest risk of receiving benzodiazepine monotherapy.
机译:目的:抑郁症指导阻止苯二氮卓类动物疗法和限制用来抗抑郁药的短期辅助治疗; 然而,抑郁症患者继续接受苯并二氮卓类药物治疗。此前尚未描述这种处方模式的患病率和预测因子,并有助于协助临床医生鉴定接受苯二氮卓毒药的最高风险的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号